beta blocker: be used for myocardial infarction

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be used for myocardial infarction 1.00
be used for infarction 0.93
be contraindicated in aortic stenosis 0.85
be risk factor for ischemia 0.84
be used in esophageal varices 0.82
be called cystic fibrosis 0.81
be contraindicated in pulmonary edema 0.81
cause orthostatic hypotension 0.81
be contraindicated in peripheral vascular disease 0.81
be called fibrosis 0.80

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.47
Rule weight: 0.66
Evidence weight: 0.84
Similarity weight: 0.85
Evidence: 0.63
Plausible(vasodilator, be contraindicated in aortic stenosis)
Evidence: 0.44
¬ Typical(beta blocker, be used for myocardial infarction)
0.47
Rule weight: 0.66
Evidence weight: 0.88
Similarity weight: 0.81
Evidence: 0.72
Plausible(vasodilator, cause orthostatic hypotension)
Evidence: 0.44
¬ Typical(beta blocker, be used for myocardial infarction)
0.47
Rule weight: 0.66
Evidence weight: 0.83
Similarity weight: 0.84
Evidence: 0.62
Plausible(high blood pressure, be risk factor for ischemia)
Evidence: 0.44
¬ Typical(beta blocker, be used for myocardial infarction)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.71
Similarity weight: 0.84
Evidence: 0.53
Plausible(beta blocker, be used for myocardial infarction)
Evidence: 0.62
¬ Plausible(high blood pressure, be risk factor for ischemia)
0.06
Rule weight: 0.09
Evidence weight: 0.70
Similarity weight: 0.85
Evidence: 0.53
Plausible(beta blocker, be used for myocardial infarction)
Evidence: 0.63
¬ Plausible(vasodilator, be contraindicated in aortic stenosis)
0.05
Rule weight: 0.09
Evidence weight: 0.66
Similarity weight: 0.81
Evidence: 0.53
Plausible(beta blocker, be used for myocardial infarction)
Evidence: 0.72
¬ Plausible(vasodilator, cause orthostatic hypotension)

Remarkability exclusitivity betweem a parent and a child

0.20
Rule weight: 0.58
Evidence weight: 0.43
Similarity weight: 0.81
Evidence: 0.84
¬ Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.68
¬ Remarkable(vasodilator, cause orthostatic hypotension)
0.19
Rule weight: 0.58
Evidence weight: 0.39
Similarity weight: 0.85
Evidence: 0.84
¬ Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.73
¬ Remarkable(vasodilator, be contraindicated in aortic stenosis)
0.14
Rule weight: 0.58
Evidence weight: 0.28
Similarity weight: 0.84
Evidence: 0.84
¬ Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.86
¬ Remarkable(high blood pressure, be risk factor for ischemia)

Remarkability exclusitivity between siblings

0.02
Rule weight: 0.13
Evidence weight: 0.20
Similarity weight: 0.81
Evidence: 0.84
¬ Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.95
¬ Remarkable(cystic fibrosis, be called cystic fibrosis)

Remarkability from parent implausibility

0.34
Rule weight: 0.42
Evidence weight: 0.97
Similarity weight: 0.85
Evidence: 0.63
Plausible(vasodilator, be contraindicated in aortic stenosis)
Evidence: 0.84
Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.53
¬ Plausible(beta blocker, be used for myocardial infarction)
0.34
Rule weight: 0.42
Evidence weight: 0.97
Similarity weight: 0.84
Evidence: 0.62
Plausible(high blood pressure, be risk factor for ischemia)
Evidence: 0.84
Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.53
¬ Plausible(beta blocker, be used for myocardial infarction)
0.33
Rule weight: 0.42
Evidence weight: 0.98
Similarity weight: 0.81
Evidence: 0.72
Plausible(vasodilator, cause orthostatic hypotension)
Evidence: 0.84
Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.53
¬ Plausible(beta blocker, be used for myocardial infarction)

Remarkability from sibling implausibility

0.48
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.81
Evidence: 0.53
Plausible(beta blocker, be used for myocardial infarction)
Evidence: 0.95
Remarkable(cystic fibrosis, be called cystic fibrosis)
Evidence: 0.36
¬ Plausible(cystic fibrosis, be called cystic fibrosis)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.66
Similarity weight: 1.00
Evidence: 0.53
Plausible(beta blocker, be used for myocardial infarction)
Evidence: 0.72
¬ Salient(beta blocker, be used for myocardial infarction)

Similarity expansion

0.62
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.82
Evidence: 0.84
Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices)
0.61
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.81
Evidence: 0.84
Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema)
0.61
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.82
Evidence: 0.72
Salient(beta blocker, be used for myocardial infarction)
Evidence: 0.48
¬ Salient(beta blocker, be used in esophageal varices)
0.59
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.81
Evidence: 0.84
Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.83
¬ Remarkable(beta blocker, be contraindicated in peripheral vascular disease)
0.57
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.82
Evidence: 0.53
Plausible(beta blocker, be used for myocardial infarction)
Evidence: 0.39
¬ Plausible(beta blocker, be used in esophageal varices)
...

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.72
Salient(beta blocker, be used for myocardial infarction)
Evidence: 0.44
¬ Typical(beta blocker, be used for myocardial infarction)
Evidence: 0.84
¬ Remarkable(beta blocker, be used for myocardial infarction)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.53
Plausible(beta blocker, be used for myocardial infarction)
Evidence: 0.44
¬ Typical(beta blocker, be used for myocardial infarction)

Typicality and Rermarkability incompatibility between a parent and a child

0.24
Rule weight: 0.51
Evidence weight: 0.56
Similarity weight: 0.84
Evidence: 0.84
¬ Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.53
¬ Typical(high blood pressure, be risk factor for ischemia)
0.21
Rule weight: 0.51
Evidence weight: 0.49
Similarity weight: 0.85
Evidence: 0.84
¬ Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.61
¬ Typical(vasodilator, be contraindicated in aortic stenosis)
0.16
Rule weight: 0.51
Evidence weight: 0.38
Similarity weight: 0.81
Evidence: 0.84
¬ Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.74
¬ Typical(vasodilator, cause orthostatic hypotension)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 0.81
Evidence: 0.84
¬ Remarkable(beta blocker, be used for myocardial infarction)
Evidence: 0.12
¬ Typical(cystic fibrosis, be called cystic fibrosis)

Typicality inheritance from parent to child

0.29
Rule weight: 0.48
Evidence weight: 0.71
Similarity weight: 0.84
Evidence: 0.44
Typical(beta blocker, be used for myocardial infarction)
Evidence: 0.53
¬ Typical(high blood pressure, be risk factor for ischemia)
0.27
Rule weight: 0.48
Evidence weight: 0.66
Similarity weight: 0.85
Evidence: 0.44
Typical(beta blocker, be used for myocardial infarction)
Evidence: 0.61
¬ Typical(vasodilator, be contraindicated in aortic stenosis)
0.23
Rule weight: 0.48
Evidence weight: 0.59
Similarity weight: 0.81
Evidence: 0.44
Typical(beta blocker, be used for myocardial infarction)
Evidence: 0.74
¬ Typical(vasodilator, cause orthostatic hypotension)